Showing results (11-20 of 178) with videos related to
Sort By:
Pageof 18
Current Opinion in Rheumatology|July 11, 2025
Gastrointestinal manifestations of systemic sclerosis: current approaches and emerging therapiesLuis G Alcala-Gonzalez, Monique Hinchcliff, Zsuzsanna H McMahanThe Journal of Rheumatology|August 17, 2011
Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study populationMonique Hinchcliff, Aryeh Fischer, Elena Schiopu, et al.Current Opinion in Rheumatology|October 12, 2021
Metabolic perturbations in systemic sclerosisSteven O'ReillyImmunology Letters|September 11, 2017
Toll Like Receptors in systemic sclerosis: An emerging targetSteven O'ReillyJournal of Scleroderma and Related Disorders|April 6, 2022
Circulating Gremlin-1 is elevated in systemic sclerosis patientsSteven O'ReillyThe British Journal of Dermatology|December 26, 2025
Targeting the cGAS STING pathway for therapeutic gain in autoimmune inflammatory cutaneous diseases with a focus on systemic lupus erythematosus and systemic sclerosisSteven O'ReillyClinical and Experimental Immunology|September 19, 2023
Interleukin-11 and its eminent role in tissue fibrosis: a possible therapeutic targetSteven O'ReillyCellular and Molecular Life Sciences : CMLS|November 3, 2021
Gremlin: a complex molecule regulating wound healing and fibrosisSteven O'ReillyBiofactors (Oxford, England)|July 30, 2013
Role of interleukin-13 in fibrosis, particularly systemic sclerosisSteven O'ReillyClinical Science (London, England : 1979)|November 14, 2013
Innate immunity in systemic sclerosis pathogenesisSteven O'ReillyPageof 18